These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20450896)

  • 1. A functional polymorphism in the HMGCR promoter affects transcriptional activity but not the risk for Alzheimer disease in Swedish populations.
    Keller L; Murphy C; Wang HX; Fratiglioni L; Olin M; Gafvels M; Björkhem I; Graff C; Meaney S
    Brain Res; 2010 Jul; 1344():185-91. PubMed ID: 20450896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.
    Porcellini E; Calabrese E; Guerini F; Govoni M; Chiappelli M; Tumini E; Morgan K; Chappell S; Kalsheker N; Franceschi M; Licastro F
    Neurosci Lett; 2007 Apr; 416(1):66-70. PubMed ID: 17284348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
    Akadam-Teker B; Kurnaz O; Coskunpinar E; Daglar-Aday A; Kucukhuseyin O; Cakmak HA; Teker E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
    Gene; 2013 Oct; 528(2):93-8. PubMed ID: 23933271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk.
    Rodríguez-Rodríguez E; Mateo I; Infante J; Llorca J; García-Gorostiaga I; Vázquez-Higuera JL; Sánchez-Juan P; Berciano J; Combarros O
    Brain Res; 2009 Jul; 1280():166-71. PubMed ID: 19446537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
    Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
    Xin XY; Ding JQ; Chen SD
    J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
    Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
    Xue S; Jia L; Jia J
    Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
    Koivisto AM; Helisalmi S; Pihlajamäki J; Moilanen L; Kuusisto J; Laakso M; Hiltunen M; Keijo K; Hänninen T; Helkala EL; Kervinen K; Kesäniemi YA; Soininen H
    J Neurogenet; 2005; 19(3-4):155-61. PubMed ID: 16540406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
    Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
    Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
    Martínez-García A; Aldudo J; Recuero M; Sastre I; Vilella-Cuadrada E; Rosich-Estragó M; Frank A; Valdivieso F; Bullido MJ
    Dement Geriatr Cogn Disord; 2008; 26(5):440-4. PubMed ID: 18957849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
    Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.